These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24633177)

  • 1. Xmrk, kras and myc transgenic zebrafish liver cancer models share molecular signatures with subsets of human hepatocellular carcinoma.
    Zheng W; Li Z; Nguyen AT; Li C; Emelyanov A; Gong Z
    PLoS One; 2014; 9(3):e91179. PubMed ID: 24633177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Induction of Potential Warburg Effect in Zebrafish Hepatocellular Carcinoma by Co-Transgenic Expression of Myc and xmrk Oncogenes.
    Li Z; Zheng W; Li H; Li C; Gong Z
    PLoS One; 2015; 10(7):e0132319. PubMed ID: 26147004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transgenic zebrafish liver tumor model with inducible Myc expression reveals conserved Myc signatures with mammalian liver tumors.
    Li Z; Zheng W; Wang Z; Zeng Z; Zhan H; Li C; Zhou L; Yan C; Spitsbergen JM; Gong Z
    Dis Model Mech; 2013 Mar; 6(2):414-23. PubMed ID: 23038063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible and repressable oncogene-addicted hepatocellular carcinoma in Tet-on xmrk transgenic zebrafish.
    Li Z; Huang X; Zhan H; Zeng Z; Li C; Spitsbergen JM; Meierjohann S; Schartl M; Gong Z
    J Hepatol; 2012 Feb; 56(2):419-25. PubMed ID: 21888874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafish.
    Nguyen AT; Emelyanov A; Koh CH; Spitsbergen JM; Lam SH; Mathavan S; Parinov S; Gong Z
    Dis Model Mech; 2011 Nov; 4(6):801-13. PubMed ID: 21729876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical inhibition reveals differential requirements of signaling pathways in kras
    Yan C; Yang Q; Huo X; Li H; Zhou L; Gong Z
    Sci Rep; 2017 Apr; 7():45796. PubMed ID: 28378824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myc-induced liver tumors in transgenic zebrafish can regress in tp53 null mutation.
    Sun L; Nguyen AT; Spitsbergen JM; Gong Z
    PLoS One; 2015; 10(1):e0117249. PubMed ID: 25612309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of liver stromal cells is associated with male-biased liver tumor initiation in xmrk and Myc transgenic zebrafish.
    Yang Q; Yan C; Gong Z
    Sci Rep; 2017 Sep; 7(1):10315. PubMed ID: 28871112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inducible kras(V12) transgenic zebrafish model for liver tumorigenesis and chemical drug screening.
    Nguyen AT; Emelyanov A; Koh CH; Spitsbergen JM; Parinov S; Gong Z
    Dis Model Mech; 2012 Jan; 5(1):63-72. PubMed ID: 21903676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.
    Santoni-Rugiu E; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1999 Jun; 154(6):1693-700. PubMed ID: 10362794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversion of tumor hepatocytes to normal hepatocytes during liver tumor regression in an oncogene-expressing transgenic zebrafish model.
    Li Y; Agrawal I; Gong Z
    Dis Model Mech; 2019 Oct; 12(10):. PubMed ID: 31515263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a conditional liver tumor model by mifepristone-inducible Cre recombination to control oncogenic kras V12 expression in transgenic zebrafish.
    Nguyen AT; Koh V; Spitsbergen JM; Gong Z
    Sci Rep; 2016 Jan; 6():19559. PubMed ID: 26790949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic analysis of a transgenic zebrafish hepatocellular carcinoma model reveals a prominent role of immune responses in tumour progression and regression.
    Li Z; Luo H; Li C; Huo X; Yan C; Huang X; Al-Haddawi M; Mathavan S; Gong Z
    Int J Cancer; 2014 Oct; 135(7):1564-73. PubMed ID: 24550086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogene-specific gene expression signatures at preneoplastic stage in mice define distinct mechanisms of hepatocarcinogenesis.
    Coulouarn C; Gomez-Quiroz LE; Lee JS; Kaposi-Novak P; Conner EA; Goldina TA; Onishchenko GE; Factor VM; Thorgeirsson SS
    Hepatology; 2006 Oct; 44(4):1003-11. PubMed ID: 17006931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer.
    Dauch D; Rudalska R; Cossa G; Nault JC; Kang TW; Wuestefeld T; Hohmeyer A; Imbeaud S; Yevsa T; Hoenicke L; Pantsar T; Bozko P; Malek NP; Longerich T; Laufer S; Poso A; Zucman-Rossi J; Eilers M; Zender L
    Nat Med; 2016 Jul; 22(7):744-53. PubMed ID: 27213815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYC-regulated genes involved in liver cell dysplasia identified in a transgenic model of liver cancer.
    Hunecke D; Spanel R; Länger F; Nam SW; Borlak J
    J Pathol; 2012 Dec; 228(4):520-33. PubMed ID: 22653869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sex hormones on liver tumor progression and regression in Myc/xmrk double oncogene transgenic zebrafish.
    Li H; Lu JW; Huo X; Li Y; Li Z; Gong Z
    Gen Comp Endocrinol; 2019 Jun; 277():112-121. PubMed ID: 30926469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A ΔRaf1-ER-inducible oncogenic zebrafish liver cell model identifies hepatocellular carcinoma signatures.
    He S; Krens SG; Zhan H; Gong Z; Hogendoorn PC; Spaink HP; Snaar-Jagalska BE
    J Pathol; 2011 Sep; 225(1):19-28. PubMed ID: 21744342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.